CCND1 and central nervous system cancer: Figure 5 shows the stochastic temporal responses of cyclin D1 and GFAP, the distribution of GFAP levels and the differentiation potential of glioma cells evaluated after 48 h of drug treatment (CT = 10 ng/ml).